Targeting spike protein-induced TLR/NET axis by COVID-19 therapeutic NRICM102 ameliorates pulmonary embolism and fibrosis

The global COVID-19 pandemic remains a critical public health threat, as existing vaccines and drugs appear insufficient to halt the rapid transmission. During an outbreak from May to August 2021 in Taiwan, patients with severe COVID-19 were administered NRICM102, which was a traditional Chinese med...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Wen-Chi, Liaw, Chia-Ching, Tsai, Keng-Chang, Chiou, Chun-Tang, Tseng, Yu-Hwei, Chiou, Wen-Fei, Lin, Yu-Chi, Tsai, Chia-I, Lin, Chen-Shien, Lin, Chen-Sung, Liou, Kuo-Tong, Yu, I-Shing, Shen, Yuh-Chiang, Su, Yi-Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9443660/
https://www.ncbi.nlm.nih.gov/pubmed/36064077
http://dx.doi.org/10.1016/j.phrs.2022.106424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9443660/
https://www.ncbi.nlm.nih.gov/pubmed/36064077
http://dx.doi.org/10.1016/j.phrs.2022.106424

Ejemplares similares